## Background: The 46,193 men aged 45 to 80 years registered in the electoral roll of quebec city and its metropolitan area were randomized in november 1988 between screening and no screening in a study aimed of assessing the impact of prostate cancer screening on cause-specific death. ## Methods:
The Quebec study shows a 69% decrease in prostate cancer death
β Scribed by Labrie, Fernand; Candas, Bernard
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 54 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Prostate specific antigen (PSA) screening was introduced to detect prostate cancer at an early stage and to reduce prostate cancerβspecific mortality. Until results from clinical trials are available, the efficacy of PSA screening in reducing prostate cancer mortality can be estimated b
## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a caseβcon